Most people on Ozempic lose about 1 to 2 pounds per week on average, though the actual number varies widely depending on your dose, how long you’ve been on the medication, and your starting weight. In the first month, weight loss tends to be modest because the dose starts low. The pace picks up as the dose increases, then gradually levels off after about a year.
That said, weekly weight loss is not linear. You might lose nothing one week and three pounds the next. Averages from clinical trials are more useful than any single week’s number for setting realistic expectations.
What the Clinical Trials Show
The best data comes from the STEP 1 trial, which studied semaglutide (the active ingredient in both Ozempic and Wegovy) at the 2.4 mg dose in people with obesity or overweight. Participants lost an average of 3.8% of their body weight in the first four weeks. For someone starting at 220 pounds, that works out to roughly 8 pounds over four weeks, or about 2 pounds per week.
By three months, participants had lost an average of 9.6% of their starting weight. At six months, that climbed to 13.8%. After 68 weeks (about 16 months), the average total weight loss was 14.9% of baseline body weight, compared to just 2.4% in people taking a placebo. For a 220-pound starting weight, 14.9% translates to roughly 33 pounds.
Those numbers reflect the higher dose used for weight management. Ozempic is FDA-approved specifically for type 2 diabetes, not weight loss, and its maximum dose (2 mg) is slightly lower than the 2.4 mg dose studied in the STEP trials and used in Wegovy. So if you’re taking Ozempic, your results may run slightly below the trial figures.
Why the First Few Weeks Are Slower
Ozempic uses a gradual dose escalation schedule. You start at 0.25 mg for the first four weeks, then move to 0.5 mg, and so on. The dose increases roughly every four weeks until you reach your target. This ramp-up exists to reduce nausea and other gastrointestinal side effects, but it also means the appetite-suppressing effects are mild at first.
During weeks one through four at the lowest dose, some people notice only a slight reduction in hunger and lose little to no weight. Others drop a few pounds quickly, often partly from water loss and reduced food intake. The real momentum typically builds once you reach a higher dose, usually around weeks 9 through 16.
How Starting Weight and Health Affect Results
People with more weight to lose often see larger absolute numbers on the scale, especially early on. But the percentage of body weight lost is what researchers track, and that number is influenced by metabolic health more than size alone.
A study published in EClinicalMedicine found that people with less severe type 2 diabetes lost significantly more weight on semaglutide than those with more advanced diabetes. At 12 months, people in the mildest diabetes category lost an average of 8.8% of their body weight, while those in the most severe category lost 5.0%. The difference was statistically significant. Insulin resistance, how long you’ve had diabetes, and the number of diabetes medications you take all appear to blunt the weight loss effect.
If you don’t have type 2 diabetes and are using semaglutide primarily for weight, your results will likely track closer to the higher end of the STEP trial data. Age and sex also play a role, though the effects are smaller than metabolic health.
When Weight Loss Slows Down
Weight loss on semaglutide does not continue indefinitely. Most people hit a plateau around 60 weeks (roughly 14 months). At that point, the body has adapted to the lower calorie intake and the medication’s effects on appetite, and weight stabilizes.
This plateau is normal and expected. It does not mean the medication has stopped working. Semaglutide continues to help maintain the weight you’ve lost, which is itself a significant benefit. Without the medication, studies show most people regain a substantial portion of lost weight within a year of stopping.
The weight loss curve looks something like this: slow start in weeks 1 through 4, accelerating loss from months 2 through 6, gradual tapering from months 6 through 12, and a plateau somewhere between months 12 and 15. Your weekly rate during the fastest phase might be 1.5 to 2.5 pounds per week. During the plateau, it drops to near zero.
Realistic Weekly Expectations by Phase
- Weeks 1 to 4 (lowest dose): 0 to 2 pounds per week. Some weeks you may see no change at all.
- Weeks 5 to 16 (dose escalation): 1 to 2 pounds per week as appetite suppression strengthens with each dose increase.
- Weeks 17 to 40 (full dose, active loss phase): 1 to 2.5 pounds per week for most people. This is when the bulk of weight loss happens.
- Weeks 40 to 60 (deceleration): Under 1 pound per week as your body approaches a new equilibrium.
- Beyond 60 weeks: Weight typically stabilizes. Continued use helps prevent regain.
These ranges assume you’re also making changes to diet and physical activity, which was required of all participants in the STEP trials. Semaglutide reduces appetite and slows stomach emptying, but the calorie deficit still has to come from eating less or moving more.
Why Weekly Weigh-Ins Can Be Misleading
Body weight fluctuates by 2 to 5 pounds daily based on water retention, sodium intake, bowel habits, and hormonal shifts. A single week is too short a window to judge whether Ozempic is working. You could retain water from a salty meal, gain temporary weight from constipation (a common side effect of semaglutide), or see a misleading spike from menstrual cycle changes.
A more reliable approach is to track your weight over four-week intervals and look at the trend. If you’ve lost 3 to 5 pounds over a month during the active dose escalation phase, you’re on a typical trajectory. If you’ve been at your full dose for 8 or more weeks with no change in weight at all, that’s worth discussing with your prescriber, as it may signal a need to reassess diet, dose, or whether a different medication is a better fit.